Dian Diagnostics Group Co Ltd (300244):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Dian Diagnostics Group Co Ltd (300244) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7935
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Dian Diagnostics Group Co Ltd (Dian Diagnostics) is a medical diagnostic service provider. The company provides forensic authentication services, commercialization of diagnostic products, research and development in medical diagnostics and contract research services. It offers solutions in service marketing, forensic identification, health inspection, cold chain logistics, diagnostic technology research and development production, CRO, biological sample library and other field. Dian Diagnostics promotes the development of multi-service areas of third-party independent medical diagnostic platforms and integrated development strategies for upstream and downstream industry chains. It provides services to medical institutions across China. The company operates through its research and development center in Zhejiang. Dian Diagnostics is headquartered in Hangzhou, China.

Dian Diagnostics Group Co Ltd (300244) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Dian Diagnostics Group Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Dian Diagnostics Group Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Dian Diagnostics Group Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Dian Diagnostics Group Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Dian Diagnostics Group Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Dian Diagnostics Group Co Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
Ativa Medical Raises USD15 Million in Series B Financing 10
Partnerships 12
Zhejiang Dian Diagnostics Enters into Licensing Agreement with Metabolon 12
Foundation Medicine, Roche and DIAN Diagnostics Enter into Partnership 13
SCIEX forms Joint Venture with Zhejiang Dian Diagnostics in China 14
Equity Offering 15
Dian Diagnostics to Raise USD170.6 Million in Private Placement of Shares 15
Xinjiang Yuanding Medical Devices Plans to Raise USD50.4 Million in Private Placement of Shares 16
Debt Offering 17
Zhejiang DiAn Diagnostics Raises USD123 Million in First Tranche of Public Offering of 3.25% Bonds Due 2021 17
Acquisition 18
Zhejiang Dian to Acquire 64% Stake in Guangzhou-Based Medical Appliances Company for USD151.5 Million 18
Zhejiang Dian to Acquire 16.5% Stake in a Medical Instrumentation Company in China for USD5.2 Million 19
Zhejiang Dian Diagnostics to Acquire Shanxi Based Medical Equipment Company 20
Zhejiang Dian Diagnostics to Acquire 65% stake in Inner Mongolia Medical Technology from Deqing Fu Ying and Deqing Schwab Investment for USD38.8 Million 21
Zhejiang DIAN Diagnostics to Acquire Jinhua-based Company for USD8.3 Million 22
Dian Diagnostics Group Co Ltd – Key Competitors 23
Dian Diagnostics Group Co Ltd – Key Employees 24
Dian Diagnostics Group Co Ltd – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Other Significant Developments 26
Jul 10, 2018: Agena Announces MassARRAY Commercial Partnership Agreement With Dian For China Clinical Laboratory Market 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Dian Diagnostics Group Co Ltd, Medical Equipment, Key Facts, 2017 2
Dian Diagnostics Group Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Dian Diagnostics Group Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Dian Diagnostics Group Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Dian Diagnostics Group Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Dian Diagnostics Group Co Ltd, Deals By Market, 2012 to YTD 2018 8
Dian Diagnostics Group Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Ativa Medical Raises USD15 Million in Series B Financing 10
Zhejiang Dian Diagnostics Enters into Licensing Agreement with Metabolon 12
Foundation Medicine, Roche and DIAN Diagnostics Enter into Partnership 13
SCIEX forms Joint Venture with Zhejiang Dian Diagnostics in China 14
Dian Diagnostics to Raise USD170.6 Million in Private Placement of Shares 15
Xinjiang Yuanding Medical Devices Plans to Raise USD50.4 Million in Private Placement of Shares 16
Zhejiang DiAn Diagnostics Raises USD123 Million in First Tranche of Public Offering of 3.25% Bonds Due 2021 17
Zhejiang Dian to Acquire 64% Stake in Guangzhou-Based Medical Appliances Company for USD151.5 Million 18
Zhejiang Dian to Acquire 16.5% Stake in a Medical Instrumentation Company in China for USD5.2 Million 19
Zhejiang Dian Diagnostics to Acquire Shanxi Based Medical Equipment Company 20
Zhejiang Dian Diagnostics to Acquire 65% stake in Inner Mongolia Medical Technology from Deqing Fu Ying and Deqing Schwab Investment for USD38.8 Million 21
Zhejiang DIAN Diagnostics to Acquire Jinhua-based Company for USD8.3 Million 22
Dian Diagnostics Group Co Ltd, Key Competitors 23
Dian Diagnostics Group Co Ltd, Key Employees 24
Dian Diagnostics Group Co Ltd, Subsidiaries 25

List of Figures
Dian Diagnostics Group Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Dian Diagnostics Group Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Dian Diagnostics Group Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Dian Diagnostics Group Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Dian Diagnostics Group Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Dian Diagnostics Group Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Dian Diagnostics Group Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Dian Diagnostics Group Co Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Dian Diagnostics Group Co Ltd (300244):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gliknik Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Gliknik Inc (Gliknik) is a biopharmaceutical company that develops therapies for patients suffering from cancer and immune disorders. The company’s pipeline products include biropepimut-S (GL-0817) and GL-2045. Its biropepimut-S is an engineered peptide immunomodulator targeted against impor …
  • Goteborg Energi AB:発電所・企業SWOT分析
    Goteborg Energi AB - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Catholic Health Initiatives:製薬・医療:M&Aディール及び事業提携情報
    Summary Catholic Health Initiatives (CHI) is a health system comprising of non-profit and for profit corporations and other organizations including Catholic health care systems. It serves people through operations and facilities that span the continuum of care, comprising acute care hospitals; long- …
  • Marinus Pharmaceuticals Inc (MRNS):企業の財務・戦略的SWOT分析
    Summary Marinus Pharmaceuticals Inc (Marinus Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes medicines for the treatment of epilepsy and other neuropsychiatric disorders. The company is evaluating its lead product candidate Ganaxolone, a gamma-aminobutyri …
  • RAK Petroleum Plc (RAKP):企業の財務・戦略的SWOT分析
    Summary RAK Petroleum Plc (RAK Petroleum), a subsidiary of RAK Investment Auhtority, is oil and gas company that transports and trades oil, gas and petrochemicals. The company carries out upstream, midstream and downstream activities. It operates its projects in the Middle East and Africa. RAK Petro …
  • BDO International Ltd:企業の戦略的SWOT分析
    BDO International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Synergy Pharmaceuticals Inc:企業の戦略的SWOT分析
    Synergy Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • 3P Biopharmaceuticals SL-製薬・医療分野:企業M&A・提携分析
    Summary 3P Biopharmaceuticals SL (3P), a subsidiary of Infarco SA is a biotechnology company that offers biological and cell therapy products. The company offers biologic services such as cell-banks, process development, GMP manufacturing and analytical QC services. Its cell therapy services compris …
  • Schreiber Foods Inc:企業の戦略的SWOT分析
    Schreiber Foods Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Firestone Diamonds plc:企業の戦略・SWOT・財務情報
    Firestone Diamonds plc - Strategy, SWOT and Corporate Finance Report Summary Firestone Diamonds plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Mymetics Corp (MYMX)-製薬・医療分野:企業M&A・提携分析
    Summary Mymetics Corp (Mymetics) is a biotechnology company that develops next-generation prophylactic vaccines for infectious diseases. The company's product pipeline includes vaccine candidates that target HIV-1/AIDS, chikungunya, intranasal influenza, malaria, herpes simplex virus (HSV) and respi …
  • Ornim Inc-医療機器分野:企業M&A・提携分析
    Summary Ornim Inc (Ornim) is a medical device company that specializes in clinical research, development, and distribution of medical devices in the field of tissue and cerebral blood flow and perfusion. The company’s c-FLOW is a continuous non-invasive monitor of deep tissue blood flow that is used …
  • Proengin:企業の戦略・SWOT・財務情報
    Proengin - Strategy, SWOT and Corporate Finance Report Summary Proengin - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Argenx SE (ARGX):企業の財務・戦略的SWOT分析
    Summary Argenx SE (Argenx) is a human antibodies developer. The company offers autoimmunity and oncology products. Its wholly owned product candidates include ARGX-113, ARGX-110, ARGX-117 and ARGX-111. Argenx partnered product candidates are ARGX-109, ARGX-112, ARGX-115 AND ARGX-116. The company off …
  • Sodra Skogsagarna ekonomisk forening:企業の戦略的SWOT分析
    Sodra Skogsagarna ekonomisk forening - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Zetro Aerospace Corporation Sdn. Bhd.:企業の戦略・SWOT・財務情報
    Zetro Aerospace Corporation Sdn. Bhd. - Strategy, SWOT and Corporate Finance Report Summary Zetro Aerospace Corporation Sdn. Bhd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Republic National Distributing Company:戦略・SWOT・企業財務分析
    Republic National Distributing Company - Strategy, SWOT and Corporate Finance Report Summary Republic National Distributing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • AbGenomics International Inc-製薬・医療分野:企業M&A・提携分析
    Summary AbGenomics International Inc (AbGenomics) is a biopharmaceutical company that develops therapeutics for inflammatory diseases and cancers. The company provides products such as pipeline products, monoclonal antibody products, therapeutic products, neihulizumab, bio-therapeutics, and biobette …
  • Armetheon Inc-製薬・医療分野:企業M&A・提携分析
    Summary Armetheon Inc (Armetheon) is a drug development company that develops novel small molecule drugs for treatment of cardiovascular diseases with high unmet medical need. The company develops anticoagulants and antibiotics that make use of the antibiotic resistance mechanisms to provide bacteri …
  • Foraco International SA (FAR):企業の財務・戦略的SWOT分析
    Summary Foraco International SA (Foraco) is a provider of drilling solutions for mining, energy, water and infrastructure projects. The company's drilling solutions include hydrogeological drilling, deep directional drilling, metallurgical sampling and large diameter drilling. It provides geological …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆